182 related articles for article (PubMed ID: 36463277)
1. Splenic-targeting biomimetic nanovaccine for elevating protective immunity against virus infection.
Huo J; Zhang A; Wang S; Cheng H; Fan D; Huang R; Wang Y; Wan B; Zhang G; He H
J Nanobiotechnology; 2022 Dec; 20(1):514. PubMed ID: 36463277
[TBL] [Abstract][Full Text] [Related]
2. Thermostable T Cell Multiepitope Nanoparticle Antigens Inducing Potent Immune Responses against the Swine Fever Virus.
Sun L; Niu J; Zhang J; Peng Y; Feng X; Huang F; Liu J; Li S; Chen Z
ACS Infect Dis; 2023 Nov; 9(11):2358-2368. PubMed ID: 37861250
[TBL] [Abstract][Full Text] [Related]
3. Advancing vaccine development: Evaluation of a mannose-modified lipid nanoparticle-based candidate for African swine fever p30 mRNA vaccine eliciting robust immune response in mice.
Gong L; Zhang Y; Wang L; Zhao X; Wang L; Qiu X; Yang X; Zhu W; Lv L; Kang Y; Wu Y; Zhang A; Du Y; Wang X; Zhang G; Sun A; Zhuang G
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132432. PubMed ID: 38761609
[TBL] [Abstract][Full Text] [Related]
4. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity and immunogenicity of recombinant proteins comprising African swine fever virus proteins p30 and p54 fused to a cell-penetrating peptide.
Zhang G; Liu W; Gao Z; Yang S; Zhou G; Chang Y; Ma Y; Liang X; Shao J; Chang H
Int Immunopharmacol; 2021 Dec; 101(Pt A):108251. PubMed ID: 34715492
[TBL] [Abstract][Full Text] [Related]
6. Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technology.
Baruah N; Ahamad N; Halder P; Koley H; Katti DS
J Nanobiotechnology; 2023 Jan; 21(1):34. PubMed ID: 36710326
[TBL] [Abstract][Full Text] [Related]
7. Development and Immunological Evaluation of a Multiantigen Thermostable Nanovaccine Adjuvanted with T-Cell-Activating Scaffold for African Swine Fever.
Sun L; Zhang J; Shi L; Peng Y; Feng X; Huang F; Yang F; Li J; Wang S; Niu J; Liu J; Li Y; Li S; Chen Z
ACS Appl Bio Mater; 2024 Mar; 7(3):1547-1557. PubMed ID: 38346262
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembling Nanovaccine Enhances Protective Efficacy Against CSFV in Pigs.
Liu ZH; Xu HL; Han GW; Tao LN; Lu Y; Zheng SY; Fang WH; He F
Front Immunol; 2021; 12():689187. PubMed ID: 34367147
[TBL] [Abstract][Full Text] [Related]
9. Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens.
Lin SY; Yao BY; Hu CJ; Chen HW
Int J Nanomedicine; 2020; 15():3303-3318. PubMed ID: 32494131
[TBL] [Abstract][Full Text] [Related]
10. Application of Biomimetic Cell-Derived Nanoparticles with Mannose Modification as a Novel Vaccine Delivery Platform against Teleost Fish Viral Disease.
Zhang C; Zhang PQ; Guo S; Chen G; Zhao Z; Wang GX; Zhu B
ACS Biomater Sci Eng; 2020 Dec; 6(12):6770-6777. PubMed ID: 33320639
[TBL] [Abstract][Full Text] [Related]
11. Expression library immunization can confer protection against lethal challenge with African swine fever virus.
Lacasta A; Ballester M; Monteagudo PL; Rodríguez JM; Salas ML; Accensi F; Pina-Pedrero S; Bensaid A; Argilaguet J; López-Soria S; Hutet E; Le Potier MF; Rodríguez F
J Virol; 2014 Nov; 88(22):13322-32. PubMed ID: 25210179
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of CpG-ODN-adjuvanted polyanhydride-based intranasal influenza nanovaccine in pigs.
Dhakal S; Ghimire S; Renu S; Ross KA; Lakshmanappa YS; Hogshead BT; Bernardo P; Lee CW; Wannemuehler MJ; Narasimhan B; Renukaradhya GJ
Vet Microbiol; 2019 Oct; 237():108401. PubMed ID: 31585639
[TBL] [Abstract][Full Text] [Related]
13. Polyanhydride nanovaccine against swine influenza virus in pigs.
Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
[TBL] [Abstract][Full Text] [Related]
14. BA71ΔCD2: a New Recombinant Live Attenuated African Swine Fever Virus with Cross-Protective Capabilities.
Monteagudo PL; Lacasta A; López E; Bosch L; Collado J; Pina-Pedrero S; Correa-Fiz F; Accensi F; Navas MJ; Vidal E; Bustos MJ; Rodríguez JM; Gallei A; Nikolin V; Salas ML; Rodríguez F
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814514
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses.
Liu L; Cao F; Liu X; Wang H; Zhang C; Sun H; Wang C; Leng X; Song C; Kong D; Ma G
ACS Appl Mater Interfaces; 2016 May; 8(19):11969-79. PubMed ID: 27088457
[TBL] [Abstract][Full Text] [Related]
16. Antigenic and immunogenic properties of recombinant proteins consisting of two immunodominant African swine fever virus proteins fused with bacterial lipoprotein OprI.
Zhang G; Liu W; Gao Z; Chang Y; Yang S; Peng Q; Ge S; Kang B; Shao J; Chang H
Virol J; 2022 Jan; 19(1):16. PubMed ID: 35062983
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cell-Targeted Nanovaccine Delivery System Prepared with an Immune-Active Polymer.
Rajput MKS; Kesharwani SS; Kumar S; Muley P; Narisetty S; Tummala H
ACS Appl Mater Interfaces; 2018 Aug; 10(33):27589-27602. PubMed ID: 30048112
[TBL] [Abstract][Full Text] [Related]
18. Cellular immunity in ASFV responses.
Takamatsu HH; Denyer MS; Lacasta A; Stirling CM; Argilaguet JM; Netherton CL; Oura CA; Martins C; Rodríguez F
Virus Res; 2013 Apr; 173(1):110-21. PubMed ID: 23201582
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies.
Argilaguet JM; Pérez-Martín E; Nofrarías M; Gallardo C; Accensi F; Lacasta A; Mora M; Ballester M; Galindo-Cardiel I; López-Soria S; Escribano JM; Reche PA; Rodríguez F
PLoS One; 2012; 7(9):e40942. PubMed ID: 23049728
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of mammalian cell derived and Modified Vaccinia Ankara vectored African swine fever subunit antigens in swine.
Lopera-Madrid J; Osorio JE; He Y; Xiang Z; Adams LG; Laughlin RC; Mwangi W; Subramanya S; Neilan J; Brake D; Burrage TG; Brown WC; Clavijo A; Bounpheng MA
Vet Immunol Immunopathol; 2017 Mar; 185():20-33. PubMed ID: 28241999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
